PharmaCyte Biotech

+$0.03 (+1.36%) As of 3:10 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PMCB and other ETFs, options, and stocks.

About PMCB

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes.

CEO
Kenneth L. Waggoner
Employees
4
Headquarters
Laguna Hills, California
Founded
1996

PMCB Key Statistics

Market cap
46.42M
Price-Earnings ratio
—
Dividend yield
—
Average volume
98.39K
High today
$2.28
Low today
$2.22
Open price
$2.22
Volume
3.09K
52 Week high
$21.45
52 Week low
$0.009

PMCB Earnings

-$0.64
-$0.43
-$0.21
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
— per share
Actual
Expected Jul 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure